Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May 3:9:421-30.
doi: 10.2147/COPD.S51012. eCollection 2014.

Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease

J Andrew Woods  1 , James S Wheeler  1 , Christopher K Finch  2 , Nathan A Pinner  3
Affiliations
Review

Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease

J Andrew Woods et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a chronic and progressive disease that affects an estimated 10% of the world's population over the age of 40 years. Worldwide, COPD ranks in the top ten for causes of disability and death. Given the significant impact of this disease, it is important to note that acute exacerbations of COPD (AECOPD) are by far the most costly and devastating aspect of disease management. Systemic steroids have long been a standard for the treatment of AECOPD; however, the optimal strategy for dosing and administration of these medications continues to be debated.

Objective: To review the use of corticosteroids in the treatment of acute exacerbations of COPD.

Materials and methods: Literature was identified through PubMed Medline (1950-February 2014) and Embase (1950-February 2014) utilizing the search terms corticosteroids, COPD, chronic bronchitis, emphysema, and exacerbation. All reference citations from identified publications were reviewed for possible inclusion. All identified randomized, placebo-controlled trials, meta-analyses, and systematic reviews evaluating the efficacy of systemic corticosteroids in the treatment of AECOPD were reviewed and summarized.

Results: The administration of corticosteroids in the treatment of AECOPD was assessed. In comparison to placebo, systemic corticosteroids improve airflow, decrease the rate of treatment failure and risk of relapse, and may improve symptoms and decrease the length of hospital stay. Therefore, corticosteroids are recommended by all major guidelines in the treatment of AECOPD. Existing literature suggests that low-dose oral corticosteroids are as efficacious as high-dose, intravenous corticosteroid regimens, while minimizing adverse effects. Recent data suggest that shorter durations of corticosteroid therapy are as efficacious as the traditional treatment durations currently recommended by guidelines.

Conclusion: Systemic corticosteroids are efficacious in the treatment of AECOPD and considered a standard of care for patients experiencing an AECOPD. Therefore, systemic corticosteroids should be administered to all patients experiencing AECOPD severe enough to seek emergent medical care. The lowest effective dose and shortest duration of therapy should be considered.

Keywords: chronic obstructive pulmonary disease; exacerbation.

PubMed Disclaimer

References

    1. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523–532. - PubMed
    1. National Heart, Lung, and Blood Institute . Morbidity and Mortality: Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda (MD): US Department of Health and Human Services, Public Health Service, National Institutes of Health; 2012. [Accessed March 17, 2014]. Available from: http://www.nhlbi.nih.gov/resources/docs/cht-book.htm.
    1. Mathers C, Boerma T, Fat DM. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization; 2008.
    1. Murphy SL, Xu JQ, Kochanek KD. Death: preliminary data for 2008. Natl Vital Stat Rep. 2012;60:1–51. - PubMed
    1. global initiative for chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Bethesda (MD): 2013. [Accessed March 17, 2014]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.

MeSH terms

Substances